Evoke Neuroscience, Inc.

New York, NY · Medtech · Acquired

FDA-cleared medical device that acquires, stores, and displays brain electrical activity (EEG) for diagnostic purposes

evokeneuroscience.com →
Grants
$50K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$1.7M
11 awards · Defense
#243 of 4531 in medtech
Patents
16
15 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Report Analysis Credits (hipaa Security)$99,370
Federal contractDepartment of Defense · Igf::ot::igf Evoke Assessments$26,910
Federal contractDepartment of Defense · Evoke Eeg Caps$11,820
Federal contractDepartment of Defense · Igf::ot::igf Evox Report Service$149,250
Federal grantDepartment of Defense · Phase I · Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need$49,745
Federal contractDepartment of Defense · Complete Evox System$126,035
Federal contractDepartment of Defense · Evox Machines, Reports, And Associated Supplies.$924,586
Federal contractDepartment of Defense · Prds - Evoke Report Service$59,700
Federal contractDepartment of Defense · Evox Report$59,700
Federal contractDepartment of Defense · Evoke Summary Report$56,715
Federal contractDepartment of Defense · Evoke Summary Report$56,715
Federal contractDepartment of Defense · Evox Summary Reports For The Evoke Brain Health System$113,430
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
240Sofie Biosciences, Inc.$1.7M$9.7M
241CytoViva Inc$1.7M$785K
242DIAPEDIA, LLC$1.7M—
243Evoke Neuroscience, Inc.$1.7M—
244INFRAREDX INC$1.7M$57M
245NEW HEALTH SCIENCES, INC.$1.7M—
246ALA SCIENTIFIC INSTRUMENTS INC$1.6M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 15 granted of 16

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.